Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00619385 · ClinicalTrials.gov registry record · Phase 1
A Safety and Pharmacokinetic Study of Proellex®
A Phase 1 study, sponsored by Repros Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT00619385 is a Phase 1 study that has completed, run by Repros Therapeutics. The registered enrollment target is 25 participants.
The verdict
NCT00619385, a Phase 1 study, has completed, sponsored by Repros Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
Dose escalating study of 7 daily doses of Proellex at 100 mg, 150 mg and 200 mg
Interventions
- DRUG Proellex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00619385
The ClinicalTrials.gov registry entry for NCT00619385 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Repros Therapeutics, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proellex is the first listed.
NCT00619385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00619385 about?
NCT00619385 is a clinical study titled "A Safety and Pharmacokinetic Study of Proellex®". Dose escalating study of 7 daily doses of Proellex at 100 mg, 150 mg and 200 mg
What is the current status of trial NCT00619385?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2008-02. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00619385?
The interventions under investigation include: Proellex (DRUG).
Who is sponsoring clinical trial NCT00619385?
This trial is sponsored by Repros Therapeutics, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.